Glaxo defends safety of weight loss drug alli (Newsday)
WASHINGTON (AP) — British drugmaker GlaxoSmithKline is scrambling to shore up the safety image of its weight loss pill alli, after watching sales dive on news that federal regulators are investigating the drug. Alli has received a high-profile marketing push as the first over-the-counter weight loss medication, complete with television ads and a celebrity endorsement from country singer Wynonna …
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
